Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

Micrografts promote hair growth in androgenetic alopecia treatment.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Treat pattern hair loss with finasteride and topical minoxidil.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Biologics for severe asthma have known side effects, but some new risks need more study.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Adding the topical gel improved hair growth more than using minoxidil or finasteride alone.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Higher fluence in hair removal damages hair follicles more, while lower fluence mimics natural hair regression, with long-term IPL treatments effectively reducing hair.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.